Patents-Review.com
🔗 Permalink
Assignee profile:

ADS Therapeutics LLC

City:

Irvine, California

Country:

United States

Published Applications:

10

Last publication date:

2025-01-02

Patent Grants:

10

Last grant date:

2025-12-02

Top Inventors for applications by ADS Therapeutics LLC

These are the the leading inventors for applications assigned to ADS Therapeutics LLC:

Recent patent applications by ADS Therapeutics LLC

ADS Therapeutics LLC based in Irvine, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-01-02 ✅ Patent 12,485,177 granted on 2025-12-02
US20250000980A1
Human necessities

TOPICAL OPHTHALMOLOGICAL COMPOSITIONS

 #2 | 2024-08-27 ✅ Patent 12,070,501 granted on 2024-08-27
US17976660
Human necessities

Topical ophthalmological compositions

 #3 | 2024-07-18 ✅ Patent 12,491,183 granted on 2025-12-09
US20240238279A1
Human necessities

COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION

 #4 | 2022-04-28 ✅ Patent 11,911,379 granted on 2024-02-27
US20220125783A1
Human necessities

Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization

 #5 | 2021-12-07 ✅ Patent 11,191,751 granted on 2021-12-07
US17317551
Human necessities

Topical ophthalmological atropine free base compositions

 #6 | 2021-07-29 ✅ Patent 12,156,873 granted on 2024-12-03
US20210228574A1
Human necessities

Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the same

 #7 | 2021-02-04 ✅ Patent 12,214,049 granted on 2025-02-04
US20210030889A1
Human necessities

Anti-angiogenic antibody-drug conjugates

 #8 | 2021-01-07 ✅ Patent 11,166,977 granted on 2021-11-09
US20210000860A1
Human necessities

Compositions for treating meibomian gland dysfunction

 #9 | 2020-10-15 ✅ Patent 11,246,864 granted on 2022-02-15
US20200323844A1
Human necessities

Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization

 #10 | 2020-04-23 ✅ Patent 11,179,388 granted on 2021-11-23
US20200121675A1
Human necessities

Topical composition for treating rosacea and a method for treating rosacea with the same

Also check out ADS Therapeutics LLC's (Irvine, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

372155 ⎘